key: cord-1054964-0g4s6g4t
authors: Wang, Shihang; Xu, Xuanyu; Wei, Cai; Li, Sicong; Zhao, Jingying; Zheng, Yin; Liu, Xiaoyu; Zeng, Xiaomin; Yuan, Wenliang; Peng, Sihua
title: Molecular evolutionary characteristics of SARS‐CoV‐2 emerging in the United States
date: 2021-09-20
journal: J Med Virol
DOI: 10.1002/jmv.27331
sha: 0f219ca66f9ed3218fe67b1554a88eb5121bfbdf
doc_id: 1054964
cord_uid: 0g4s6g4t

SARS‐CoV‐2 is a newly discovered beta coronavirus at the end of 2019, which is highly pathogenic and poses a serious threat to human health. In this paper, 1875 SARS‐CoV‐2 whole genome sequences and the sequence coding spike protein (S gene) sampled from the United States were used for bioinformatics analysis to study the molecular evolutionary characteristics of its genome and spike protein. The MCMC method was used to calculate the evolution rate of the whole genome sequence and the nucleotide mutation rate of the S gene. The results showed that the nucleotide mutation rate of the whole genome was 6.677 × 10(−4) substitution per site per year, and the nucleotide mutation rate of the S gene was 8.066 × 10(−4) substitution per site per year, which was at a medium level compared with other RNA viruses. Our findings confirmed the scientific hypothesis that the rate of evolution of the virus gradually decreases over time. We also found 13 statistically significant positive selection sites in the SARS‐CoV‐2 genome. In addition, the results showed that there were 101 nonsynonymous mutation sites in the amino acid sequence of S protein, including seven putative harmful mutation sites. This paper has preliminarily clarified the evolutionary characteristics of SARS‐CoV‐2 in the United States, providing a scientific basis for future surveillance and prevention of virus variants.

role. Therefore, it is very important to study the SARS-CoV-2 S protein. 11, 12 As of July 2021, the number of SARS-CoV-2 infections has reached 180 million people worldwide. As for the United States, more than 33 million COVID-19 cases have been diagnosed, which is close to a quarter of the total number of confirmed cases worldwide. The death toll in the United States exceeds 60 million. 13 In previous studies, Li et al. 12 analyzed the global evolution rate of SARS-CoV-2 in the first month of the outbreak, with an estimated mean nucleotide mutation rate ranging from 1.7926 × 10 −3 to 1.8266 × 10 −3 substitution per site per year. Four months after the outbreak, the mutation rate became 3.95 × 10 −4 per nucleotide per

year, 14 which was almost seven times lower than the mutation rate of SARS-CoV and two times lower than that of MERS-CoV. [15] [16] [17] Motayo et al. 18 reported that the evolution rate of SARS-CoV-2 in Africa from February 24 to April 24 was 4.133 × 10 −4 substitution per nucleotide per year. The Nextstrain website estimates that the annual nucleotide evolution rate is 8 × 10 −4 substitution per nucleotide per year based on current statistics. 19 As for the evolution rate of the gene encoding the S protein, Pereson et al. 20 reported that the global evolution rate was 2.19 × 10 −3 nucleotide substitutions per site per year as of April 2020, while the evolution rate reduced to 1.08 × 10 −3 as of September 2020. 21 (Table S2) . After removing the low-quality sequences (with more than 10 ambiguous nucleotides), 1875 SARS-CoV-2 genome sequences were retained for further analysis, using MN908947 (isolate from Wuhan-Hu-1) as a reference sequence.

In addition, another 69 098 S protein amino acid sequences obtained from the NCBI database were used for the mutation analysis of amino acids, which were also retrieved from the SARS-CoV-2 cases in the United States.

A multiple sequence alignment of the 1875 SARS-CoV-2 genome sequences was performed using MAFFT v7.464. 22 ModelFinder was used to analyze the optimal substitution model for the genome sequences 

The SARS-CoV-2 MN908947 was used as the reference sequence, which was aligned against the genome sequences of the other types of coronavirus by MAFFT. IQ-Tree 2.0.3 was used to establish the ML tree. 30 The CODEML program in PAML was used for the selection pressure analysis. 31 In the branch-site model, the SARS-CoV-2 was set as the foreground and the other viruses as the background. Full genomes and S gene sequences were analyzed separately to detect recombination events using RDP4 and SimPlot. 32 

To explore the evolutionary selection pressure of SARS-CoV-2, a phylogenetic analysis was carried out using MN908947 as the reference sequence, and the whole genome of MN908947 was aligned with the other 14 coronaviruses to establish the phylogenetic tree.

MN908947 was used as the foreground branch with the other 14 coronaviruses as the background branch for the branch-site model.

The analysis results are shown in Table 1 and Table S4 . Thirteen and two statistically significant positive sites were detected in the whole genome and S gene respectively (p < 0.005).

RDP4 and SimPlot were used to detect the recombination event of the 15 coronaviruses. However, the results showed that no statistically significant recombination event was found.

We found that there were 101 nonsynonymous mutations in all the 69 098 protein sequences. The results showed that there were seven harmful mutations (Table 2) , while the remaining 94 were neutral.

SARS-CoV-2 has evolved into thousands of variants worldwide. Although the virus might mutate a lot, only a few could cause serious harm to humans. 37 Compared with other coronaviruses and RNA viruses, the mutation rate of SARS-CoV-2 (6.677 × 10 −4 ) is at a medium level. Moreover, the mutation rate gradually decreased during the subsequent infection process. 12, 14, 18 The reason for this may be that SARS-CoV-2 has its own copy "proofreading mechanism", which can correct some errors that may occur during the copying process, leading to the decrease of the mutation rate of SARS-CoV-2. 38 On the other hand, harmful mutations may lead to a certain degree of protein structure and functional changes, ultimately affecting the reproduction of SARS-CoV-2. Under the pressure of natural selection and with the accumulation of harmful mutations, the number of viruses will gradually decrease and even mutational meltdown may occur, leading to population extinction, 39, 40 with a result of the relatively low evolution rate of SARS-CoV-2 (Table 3) . In addition, nonsynonymous mutations were found in many samples of the S protein, with a harmful mutation proportion of 6.93%. These harmful mutations may affect the structure and function of the S proteins. Once the amino acid of RBD of S protein is mutated, the binding affinity with the human ACE2 receptor may change, which may cause the increase of the ability to infect humans and also make the existing vaccines ineffective. 54 Global mutation data collected from the GISAID database revealed that mutations occurred at almost every site of the S gene. 55 replication cycle. From the perspective of biological evolution, the existence of viruses is a natural selection pressure for human beings.

The human body's immune response will produce a certain degree of adaptability, which will promote the development of human beings in a direction that is more conducive to human survival. However, the evolution of the human immune system and various interventions may also promote the adaptive mutations of the virus. Usually, viruses become "mild" as they circulate in the same host because high pathogenicity will lead to the death of the host, resulting in loss of transmission and reproduction, which is not conducive to the survival and reproduction of the virus itself. As mentioned above, the current mutation rate of SARS-CoV-2 in the United States is lower than that at the beginning of the outbreak. Obviously, this view is in line with our expectations.

Experimental results showed that some variants of SARS-CoV-2 strains increased the infectivity, such as variants D614G, S477N, and N439K, and these variants had higher transmission ability and faster replication speed than that of the original viruses, however, their pathogenicity did not increase. 35 In conclusion, we clarify the evolutionary characteristics of 

The authors declare that there are no conflicts of interest. 

Data derived from public domain resources.

Sihua Peng http://orcid.org/0000-0001-7231-666X

Coronavirus as a possible cause of severe acute respiratory syndrome

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A novel coronavirus associated with severe acute respiratory syndrome

A new coronavirus associated with human respiratory disease in China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread. Microb Infect

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decadelong structural studies of SARS coronavirus

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

The global spread of 2019-nCoV: a molecular evolutionary analysis

Transmission dynamics and evolutionary history of 2019-nCoV

An interactive web-based dashboard to track COVID-19 in real time

The phylogenetic relationship within SARS-CoV-2s: an expanding basal Glade

Spread, circulation, and evolution of the Middle East Respiratory Syndrome Coronavirus

Evolutionary dynamics of MERS-CoV: potential recombination, positive selection and transmission

SARS-CoV genome polymorphism: a bioinformatics study

Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences

Nextstrain: real-time tracking of pathogen evolution

Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence

Evolutionary analysis of SARS-CoV-2 spike protein for its different clades

MAFFT multiple sequence alignment software version 7: improvements in performance and usability

ModelFinder: fast model selection for accurate phylogenetic estimates

Mutation rate variation in multicellular eukaryotes: causes and consequences

BEAST 2: A Software Platform for Bayesian evolutionary analysis

Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India

Genomic epidemiology, evolution, and transmission dynamics of porcine deltacoronavirus

Transmission route and introduction of pandemic SARS-CoV-2 between China, Italy, and Spain

Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7

IQ-TREE: A fast and effective stochastic algorithm for estimating maximumlikelihood phylogenies

PAML 4: phylogenetic analysis by maximum likelihood

RDP4: detection and analysis of recombination patterns in virus genomes

Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination

PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels

Spike mutation D614G alters SARS-CoV-2 fitness

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster

The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity

Discovery of an RNA virus 3 '-> 5 ' exoribonuclease that is critically involved in coronavirus RNA synthesis

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy

The mutational meltdown in asexual populations

Evolutionary dynamics and geographic dispersal of beta coronaviruses in African bats

Mosaic structure of human coronavirus NL63, one thousand years of evolution

Attenuated live vaccine usage affects accurate measures of virus diversity and mutation rates in avian coronavirus infectious bronchitis virus

Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event

Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone

Bayesian coalescent inference of hepatitis A virus populations: evolutionary rates and patterns

The mode and tempo of hepatitis C virus evolution within and among hosts

Modeling gene sequences over time in 2009 H1N1 Influenza A Virus populations

Evolutionary dynamics of the American African genotype of dengue type 1 virus in India

Genus-specific substitution rate variability among picornaviruses

Origin of measles virus: divergence from rinderpest virus between the 11(th) and 12(th) centuries

The evolutionary history and dynamics of bat rabies virus

Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread

Bioinformatics analysis of SARS-CoV-2 strain S protein mutation and its effect

disease and diplomacy: GISAID's innovative contribution to global health

Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibodymediated immunity

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2

US COVID-19 Cases Caused by Variants

Global early transmission of the new coronavirus variant strain VOC 202012/01 and analysis of the evolutionary characteristics of the spike protein

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Second wave of COVID-19 in India: Dissection of the causes and lessons learnt

Structural analysis of the novel variants of SARS-CoV-2 and Forecasting in North America

Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States